|
|
Good manufacturing practices should not be "skin deep".(Editorial)
- Article from:
-
Alternative Medicine Review
- Article date:
-
March 1, 2008
- Author:
- Czap, A.F.
|
Copyright informationCOPYRIGHT 2008 Thorne Research Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Quality control in manufacturing, and the lack thereof, is being written about more and more, and is becoming increasingly more obfuscated.
On February 5, 2008, an Associated Press wire story highlighted "the lack thereof" in pharmaceutical quality control, revealing the incidence of blue flecks that were found dotting the finished drug capsules Diltiazem, that matched the paint on the factory doors of a Biovail pharmaceutical plant. The plant began placing covers over the carts of capsules in its manufacturing areas, but inexplicably never tried to find out whether past shipments of the drug were contaminated--or prevent contamination in the future, according to the FDA. ...